| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Proctocolectomy, Restorative | 7 | 2020 | 51 | 3.47 | Why? |
| Crohn Disease | 13 | 2020 | 959 | 2.51 | Why? |
| Digestive System Surgical Procedures | 7 | 2020 | 677 | 2.13 | Why? |
| Colitis, Ulcerative | 7 | 2020 | 1037 | 1.72 | Why? |
| Transanal Endoscopic Surgery | 3 | 2019 | 19 | 1.70 | Why? |
| Cecum | 3 | 2018 | 63 | 1.54 | Why? |
| Ileum | 5 | 2019 | 233 | 1.53 | Why? |
| Colorectal Surgery | 4 | 2020 | 394 | 1.30 | Why? |
| Colorectal Neoplasms | 5 | 2020 | 1884 | 1.09 | Why? |
| Anastomotic Leak | 2 | 2020 | 46 | 0.98 | Why? |
| Laparoscopy | 6 | 2020 | 1532 | 0.96 | Why? |
| Rectal Neoplasms | 4 | 2019 | 278 | 0.91 | Why? |
| Colon | 4 | 2019 | 669 | 0.80 | Why? |
| Surgical Stapling | 1 | 2019 | 19 | 0.79 | Why? |
| Ligation | 1 | 2019 | 84 | 0.77 | Why? |
| Adenomatous Polyposis Coli | 1 | 2018 | 11 | 0.75 | Why? |
| Pelvic Neoplasms | 1 | 2017 | 25 | 0.70 | Why? |
| Colonic Diseases | 1 | 2019 | 96 | 0.68 | Why? |
| Pelvis | 1 | 2017 | 125 | 0.66 | Why? |
| Colonic Neoplasms | 2 | 2018 | 295 | 0.65 | Why? |
| Inflammatory Bowel Diseases | 5 | 2021 | 3209 | 0.64 | Why? |
| Colonoscopy | 5 | 2020 | 738 | 0.64 | Why? |
| Rectum | 1 | 2019 | 495 | 0.59 | Why? |
| Fluorescein Angiography | 1 | 2019 | 426 | 0.59 | Why? |
| Rectal Fistula | 4 | 2019 | 38 | 0.59 | Why? |
| Adenocarcinoma | 3 | 2019 | 651 | 0.57 | Why? |
| Adalimumab | 2 | 2017 | 389 | 0.46 | Why? |
| Patient Readmission | 2 | 2020 | 1543 | 0.46 | Why? |
| Infliximab | 2 | 2017 | 502 | 0.45 | Why? |
| Preoperative Care | 2 | 2020 | 1515 | 0.44 | Why? |
| Precision Medicine | 2 | 2018 | 1477 | 0.43 | Why? |
| Tumor Necrosis Factor-alpha | 6 | 2018 | 2483 | 0.42 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.41 | Why? |
| Patient-Centered Care | 1 | 2017 | 860 | 0.38 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 1454 | 0.37 | Why? |
| Quality of Health Care | 1 | 2020 | 1948 | 0.36 | Why? |
| Surgical Procedures, Operative | 3 | 2020 | 2662 | 0.34 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.29 | Why? |
| Minimally Invasive Surgical Procedures | 3 | 2020 | 663 | 0.29 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.25 | Why? |
| Abdominal Wall | 1 | 2020 | 62 | 0.21 | Why? |
| Vascular Endothelial Growth Factor C | 1 | 2019 | 8 | 0.21 | Why? |
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 8 | 0.21 | Why? |
| Abdomen | 3 | 2018 | 424 | 0.20 | Why? |
| Tumor Escape | 1 | 2019 | 36 | 0.20 | Why? |
| Italy | 9 | 2020 | 38444 | 0.19 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.19 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.19 | Why? |
| Long Term Adverse Effects | 1 | 2020 | 119 | 0.19 | Why? |
| Fecal Incontinence | 1 | 2018 | 40 | 0.19 | Why? |
| Endoscopic Mucosal Resection | 1 | 2019 | 63 | 0.18 | Why? |
| Conversion to Open Surgery | 1 | 2018 | 35 | 0.18 | Why? |
| Intestinal Perforation | 1 | 2020 | 178 | 0.17 | Why? |
| Intestinal Obstruction | 1 | 2020 | 197 | 0.17 | Why? |
| Humans | 45 | 2021 | 930598 | 0.17 | Why? |
| Mercaptopurine | 1 | 2017 | 68 | 0.17 | Why? |
| Mesalamine | 1 | 2017 | 89 | 0.17 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.17 | Why? |
| Anal Canal | 1 | 2020 | 367 | 0.16 | Why? |
| Oncology Service, Hospital | 1 | 2020 | 314 | 0.16 | Why? |
| Anus Neoplasms | 1 | 2018 | 123 | 0.16 | Why? |
| Colectomy | 2 | 2017 | 327 | 0.16 | Why? |
| Surgical Instruments | 1 | 2017 | 145 | 0.16 | Why? |
| Proof of Concept Study | 1 | 2019 | 696 | 0.16 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.16 | Why? |
| Postoperative Period | 2 | 2017 | 651 | 0.16 | Why? |
| Endothelial Progenitor Cells | 1 | 2017 | 103 | 0.16 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.15 | Why? |
| Smoke | 1 | 2020 | 349 | 0.15 | Why? |
| Ustekinumab | 1 | 2018 | 216 | 0.15 | Why? |
| Biological Therapy | 2 | 2018 | 456 | 0.15 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Docosahexaenoic Acids | 1 | 2017 | 145 | 0.15 | Why? |
| Secondary Prevention | 2 | 2017 | 762 | 0.15 | Why? |
| Postoperative Complications | 3 | 2020 | 5861 | 0.15 | Why? |
| Quality Assurance, Health Care | 1 | 2020 | 596 | 0.15 | Why? |
| Europe | 4 | 2021 | 12702 | 0.15 | Why? |
| Carcinoma | 1 | 2018 | 256 | 0.14 | Why? |
| Operating Rooms | 3 | 2020 | 1841 | 0.14 | Why? |
| Analgesia | 1 | 2018 | 211 | 0.14 | Why? |
| Treatment Outcome | 8 | 2019 | 51732 | 0.14 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.14 | Why? |
| Lymphatic Metastasis | 1 | 2017 | 537 | 0.14 | Why? |
| Lymph Node Excision | 1 | 2017 | 362 | 0.14 | Why? |
| Colitis | 1 | 2017 | 266 | 0.13 | Why? |
| Gastrointestinal Agents | 1 | 2018 | 393 | 0.13 | Why? |
| Stem Cell Transplantation | 1 | 2019 | 531 | 0.13 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 3 | 2020 | 9706 | 0.12 | Why? |
| Patient Reported Outcome Measures | 1 | 2019 | 912 | 0.12 | Why? |
| Combined Modality Therapy | 2 | 2019 | 3395 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Video Recording | 1 | 2018 | 786 | 0.12 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.11 | Why? |
| Patient Selection | 4 | 2020 | 4560 | 0.11 | Why? |
| Recurrence | 3 | 2017 | 3675 | 0.11 | Why? |
| Pandemics | 11 | 2020 | 389249 | 0.11 | Why? |
| Physician's Role | 1 | 2020 | 853 | 0.11 | Why? |
| Female | 18 | 2020 | 380317 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.10 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Quality of Life | 2 | 2020 | 9820 | 0.09 | Why? |
| Male | 16 | 2020 | 367725 | 0.09 | Why? |
| Infection Control | 4 | 2020 | 23131 | 0.09 | Why? |
| Emergencies | 2 | 2020 | 4095 | 0.09 | Why? |
| Middle Aged | 12 | 2020 | 270681 | 0.08 | Why? |
| Retrospective Studies | 9 | 2019 | 105322 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.08 | Why? |
| Reoperation | 2 | 2020 | 544 | 0.08 | Why? |
| Adult | 13 | 2020 | 244371 | 0.08 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.08 | Why? |
| Prostatic Neoplasms | 1 | 2018 | 1637 | 0.08 | Why? |
| Ambulatory Care | 2 | 2020 | 4947 | 0.08 | Why? |
| Surgeons | 1 | 2020 | 2233 | 0.07 | Why? |
| Aged | 9 | 2020 | 215776 | 0.07 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.07 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.07 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2015 | 1545 | 0.07 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.07 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.07 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2019 | 3557 | 0.06 | Why? |
| Lesser Pelvis | 1 | 2020 | 1 | 0.06 | Why? |
| Colonic Pouches | 1 | 2020 | 17 | 0.05 | Why? |
| Proctoscopy | 1 | 2020 | 28 | 0.05 | Why? |
| Young Adult | 5 | 2018 | 93724 | 0.05 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
| Comparative Effectiveness Research | 1 | 2020 | 178 | 0.05 | Why? |
| Neoplasms, Experimental | 1 | 2019 | 67 | 0.05 | Why? |
| Risk Factors | 5 | 2020 | 71621 | 0.05 | Why? |
| Lymphatic Vessels | 1 | 2019 | 43 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Recovery of Function | 2 | 2020 | 2461 | 0.05 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Ileus | 1 | 2018 | 40 | 0.04 | Why? |
| Epoxy Compounds | 1 | 2017 | 21 | 0.04 | Why? |
| Dextran Sulfate | 1 | 2017 | 54 | 0.04 | Why? |
| Oxylipins | 1 | 2017 | 29 | 0.04 | Why? |
| Cancer Vaccines | 1 | 2019 | 136 | 0.04 | Why? |
| Abscess | 1 | 2020 | 234 | 0.04 | Why? |
| Education, Distance | 1 | 2018 | 4956 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Symporters | 1 | 2017 | 80 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2017 | 144 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2017 | 212 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Preoperative Period | 1 | 2017 | 271 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.04 | Why? |
| Medical Audit | 1 | 2017 | 218 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.04 | Why? |
| Analysis of Variance | 1 | 2019 | 950 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2019 | 1008 | 0.04 | Why? |
| Medical Overuse | 1 | 2017 | 146 | 0.03 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.03 | Why? |
| Delphi Technique | 1 | 2018 | 1257 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2019 | 1654 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2020 | 946 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.03 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Patient Education as Topic | 1 | 2020 | 1476 | 0.03 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.02 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.02 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.02 | Why? |
| Saudi Arabia | 1 | 2020 | 4423 | 0.02 | Why? |
| Frail Elderly | 1 | 2018 | 1427 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2019 | 5542 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.02 | Why? |
| Endoscopy | 1 | 2018 | 1564 | 0.02 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 1322 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.02 | Why? |
| Curriculum | 1 | 2018 | 3083 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Internet | 1 | 2018 | 6204 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Registries | 1 | 2019 | 12327 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Animals | 2 | 2019 | 78931 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |